These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31181188)

  • 1. Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges.
    Vitorino C; Silva S; Bicker J; Falcão A; Fortuna A
    Drug Discov Today; 2019 Sep; 24(9):1911-1923. PubMed ID: 31181188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in the discovery and design of intranasal antidepressants.
    Panek M; Kawalec P; Pilc A; Lasoń W
    Expert Opin Drug Discov; 2020 Oct; 15(10):1145-1164. PubMed ID: 32567398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving Effects of Peptides on Brain Malfunction and Intranasal Delivery of Those Derivatives to the Brain].
    Oka JI
    Yakugaku Zasshi; 2019; 139(5):783-791. PubMed ID: 31061348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of neuropeptides.
    Veronesi MC; Kubek DJ; Kubek MJ
    Methods Mol Biol; 2011; 789():303-12. PubMed ID: 21922417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.
    Haque S; Md S; Sahni JK; Ali J; Baboota S
    J Psychiatr Res; 2014 Jan; 48(1):1-12. PubMed ID: 24231512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to facilitate or block nose-to-brain drug delivery.
    Martins PP; Smyth HDC; Cui Z
    Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.
    Alam MI; Baboota S; Ahuja A; Ali M; Ali J; Sahni JK; Bhatnagar A
    Int J Pharm; 2014 Aug; 470(1-2):99-106. PubMed ID: 24810241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery.
    Kanazawa T; Fukuda M; Suzuki N; Suzuki T
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?
    Vidal R; Castro E; Pilar-Cuéllar F; Pascual-Brazo J; Díaz A; Rojo ML; Linge R; Martín A; Valdizán EM; Pazos A
    Curr Pharm Des; 2014; 20(23):3751-62. PubMed ID: 24180399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neurobiologic processes in treating depression.
    Thase ME
    J Clin Psychiatry; 2010 Oct; 71(10):e28. PubMed ID: 21062614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.
    Ma XC; Chu Z; Zhang XL; Jiang WH; Jia M; Dang YH; Gao CG
    Neurochem Res; 2016 Jun; 41(6):1375-80. PubMed ID: 26846142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice.
    Serralheiro A; Alves G; Fortuna A; Falcão A
    Int J Pharm; 2015 Jul; 490(1-2):39-46. PubMed ID: 25979854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery systems from nose to brain.
    Misra A; Kher G
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose-to-Brain Delivery.
    Wang Z; Xiong G; Tsang WC; Schätzlein AG; Uchegbu IF
    J Pharmacol Exp Ther; 2019 Sep; 370(3):593-601. PubMed ID: 31126978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients.
    Jin Z; Han Y; Zhang D; Li Z; Jing Y; Hu B; Sun S
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling helps in understanding antidepressants.
    Holford N
    Clin Pharmacol Ther; 2012 Aug; 92(2):155-6. PubMed ID: 22814661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.
    Ferrés-Coy A; Galofré M; Pilar-Cuéllar F; Vidal R; Paz V; Ruiz-Bronchal E; Campa L; Pazos Á; Caso JR; Leza JC; Alvarado G; Montefeltro A; Valdizán EM; Artigas F; Bortolozzi A
    Mol Psychiatry; 2016 Mar; 21(3):328-38. PubMed ID: 26100539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.